Of the 16 million people with diabetes in the United States, nearly half will develop some degree of diabetic eye disease such as diabetic retinopathy. Retinopathy is an impairment of the retina — the nerve-rich, light-sensing area in the back of the eye that is crucial for sight.
Diabetic retinopathy is the leading cause of blindness among Americans between the ages of 25 and 70. The condition typically develops without early warning signs. The damage to the eye can occur slowly and is hard to detect without regular and accurate monitoring. Detecting this disease early can save your vision.
Between 80 to 85 percent of individuals with diabetes will develop some level of retinopathy. Individuals with Type I diabetes are more likely to develop the condition than those with Type II diabetes. If patients with diabetic retinopathy are treated properly before the retina is severely damaged, they will have an excellent chance of stabilizing the disease and stopping its progress.
Diabetes is one of the leading causes of blindness in the United States.
Mann Eye Institute has the latest diagnostic and therapeutic equipment and provides a comprehensive program for the diagnosis and treatment of diabetic eye disease. Focal laser surgery, or photocoagulation, is utilized to treat retinopathy at the advanced stages. A vitrectomy may also be performed to restore vision by removing hemorrhaged areas and to repair retinal detachment.
Regular eye exams, good medical management of blood sugar and blood pressure, along with timely treatment can significantly reduce the risk of visual loss and blindness. If you have any detectable retinopathy, it’s a message to practice tighter control, reduce your blood pressure, and perhaps reconsider your exercise regimen.